Review highlights tsRNA roles in cancer diagnosis and therapy, indicating potential clinical advancements.
Transfer RNA-derived small RNAs (tsRNAs) represent an emerging category of small non-coding RNAs generated through specific cleavage of precursor or mature tRNAs. Increasingly recognized as pivotal players in the pathogenesis of complex malignancies, tsRNAs not only regulate cancer progression but also hold promising clinical potential for cancer diagnosis and treatment. This review highlights recent advances in the application of high-throughput sequencing technologies in the systematic identification of tsRNAs, with a focus on their roles in cancer diagnosis, prognostic assessment, and targeted therapy. Delving into the translational medicine dimensions of tsRNAs may provide novel strategies for molecular diagnosis and therapeutic interventions in oncology.
No takes yet. Share an insight, caveat, or question.
Pu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: